RHÖN-KLINIKUM AG has reported a stable business performance for the first half of 2026, with consolidated revenue reaching EUR 863.6 million, slightly above the previous year's EUR 833.5 million. EBITDA increased to EUR 57.0 million from EUR 46.7 million, and consolidated profit rose to EUR 22.5 million from EUR 14.7 million. The results were significantly impacted by immediate transformation costs established to offset higher personnel and material costs from previous years. The group treated 513,700 patients on an outpatient and inpatient basis from January to June, a 9% increase compared to 471,295 in the same period last year.
The company continues to focus on expanding regional healthcare networks. In Hesse, Universitätsklinikum Marburg and Lungenfachklinik Immenhausen are pooling their expertise to improve lung patient care. In Brandenburg, the newly opened child protection emergency service at the Frankfurt (Oder) site has created a strong regional network, with cooperation agreements involving the hospital, the City of Frankfurt (Oder), and the District of Oder-Spree to ensure coordinated help for affected children and adolescents.
Dr. Gunther K. Weiß, member of the Board of Management, emphasized the importance of regional networks: “Regional networks form a vital and essential part of any future healthcare system. Rigid sectoral boundaries make it more difficult to provide patients with the care they need and saddle our healthcare system with unnecessary costs. It is only when general practitioners, specialists, medical facilities, nurses and therapists work together as a team that we can pool our resources efficiently. In the face of mounting pressures, such collaboration across providers is the only way to ensure comprehensive and high-quality care to patients, especially in rural areas.”
However, the company also highlighted the challenges posed by recent legislation. Dr. Stefan Stranz, also a Board member, stated: “The Statutory Health Insurance Contribution Rate Stabilization Act imposes further burdens on hospitals. Instead of reducing bureaucracy and refocusing on patient care, the reform saddles already overburdened hospitals with even more documentation requirements, excessive budget cuts, and financial risks.”
For the full year 2026, RHÖN-KLINIKUM expects revenues of EUR 1.7 billion within a range of plus or minus 5%, and EBITDA between EUR 110 million and EUR 125 million. The company also expects moderate improvements in number of cases and cost weights compared to the previous year. However, the forecast is subject to significant uncertainties due to the unfolding legislation process, including the Hospital Reform Adjustment Act (KHAG) and the SHI Contribution Rate Stabilisation Act (GKV-BStabG), which aim to enhance quality and efficiency but may increase financial pressure on hospitals in the short term. Ongoing global crises and economic impacts, such as higher prices and supply bottlenecks, further contribute to market volatility.
The interim report for the first half of 2026 is published on the internet, available at RHÖN-KLINIKUM AG.
